T Cell News and Research

Latest T Cell News and Research

Freeze-dried tendon grafts loaded with gene therapy may provide repair injured tendons

According to study data published today in the journal Molecular Therapy, a new graft technique may provide the first effective framework around which flexor tendon tissue can reorganize as it heals.

9 Jan 2008

Taranabant shows promise for weight loss in obese people

The first clinical studies of an experimental drug have revealed that obese people who take it for 12 weeks lose weight, even at very low doses.

9 Jan 2008

Two proteins called BERT and ERNI interact in embryos to control brain development

Scientists at University College London have discovered how two proteins called BERT and ERNI interact in embryos to control when different organ systems in the body start to form, deepening our understanding of the development of the brain and nervous system and expanding our knowledge of stem cell behavior.

9 Jan 2008

Research may improve prognosis and treatment of lung cancer

A group of scientists led by Professor Xavier Pares of the Department of Biochemistry and Molecular Biology at Universitat Autonoma de Barcelona, has published a research on AKR1B10, an enzyme that is detected in large quantities only in lung cancers, particularly those caused by smoking.

8 Jan 2008

New magnetic method of delivering cells and genes to repair injured or diseased organs

Scientists have used magnetic fields and tiny iron-bearing particles to drive healthy cells to targeted sites in blood vessels.

8 Jan 2008

Discovery of 480 genes that control human cell division

A team of U.S., Israeli and German scientists used computational biology techniques to discover 480 genes that play a role in human cell division and to identify more than 100 of those genes that have an abnormal pattern of activation in cancer cells.

8 Jan 2008

Differentiation blocked in tumor stem cells

A new comparison of normal stem cells and cancer stem cells reveals that the cancer stem cells are abnormally trapped at an early stage of development.

8 Jan 2008

A look at China's most innovative health biotechnology companies

Government funds innovation but venture capital needed; Wary investors 'need to be shown the exits'; Returning 'sea turtles' bring expertise, international credibility

8 Jan 2008

Biochemist wins grant to develop cellular molecular probes capable of measuring cholesterol levels

Alejandro P. Heuck, a biochemist at the University of Massachusetts Amherst, has received a four-year, $308,000 grant from the American Heart Association to develop molecular probes capable of measuring cholesterol levels in the membranes of individual cells.

7 Jan 2008

Genital mycoplasmas are a frequent cause of congenital fetal infection

Premature babies are subject to a host of threats that can result in fetal/neonatal disease.

7 Jan 2008

Chlamydia trachomatis genome sheds light on an emerging infection

Researchers have decoded the genome of the strain of Chlamydia that causes the most severe, invasive form of the disease. Their study shows that, despite recent increases in invasive infections, the strain has remained virtually unchanged for 40 years.

7 Jan 2008

New biomarker for predicting liver cancer spread and survival discovered

New research has shown that a unique pattern of microRNAs, small RNA molecules that regulate gene activity, can accurately predict whether liver cancer will spread and whether liver cancer patients will have shorter or longer survival, even patients with early stage disease.

7 Jan 2008

Hopkins researchers paint picture of cancer-promoting culprit

They say that a picture can be worth a thousand words. This especially is true for describing the structures of molecules that function to promote cancer.

7 Jan 2008

Tracking down allergenic substances

At present, animal tests are the only way of determining whether a particular chemical can cause an allergic reaction.

7 Jan 2008

Takeda submits NDA for Alogliptin (SYR-322) in the U.S.

Takeda Pharmaceutical Company Limited (Takeda) has announced that Takeda Global Research & Development Center, Inc. submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for alogliptin (development code: SYR-322), a highly selective dipeptidyl peptidase-4 (DPP-4) inhibitor under investigation for the treatment of type 2 diabetes.

7 Jan 2008